Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
189.48
-184.48
-97.36%
Share Warrants & Outstandings
Total Reserve
765.35
2,823.02
-2,057.67
-72.89%
Shareholder's Funds
770.35
3,024.36
-2,254.01
-74.53%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
406.29
-406.29
-100.00%
Secured Loans
0.00
0.56
-0.56
-100.00%
Unsecured Loans
0.00
405.73
-405.73
-100.00%
Deferred Tax Assets / Liabilities
-41.56
26.41
-67.97
-257.36%
Other Long Term Liabilities
38.45
213.78
-175.33
-82.01%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.32
26.11
-19.79
-75.79%
Total Non-Current Liabilities
3.21
672.59
-669.38
-99.52%
Current Liabilities
Trade Payables
456.30
1,120.39
-664.09
-59.27%
Other Current Liabilities
140.17
321.11
-180.94
-56.35%
Short Term Borrowings
0.00
249.53
-249.53
-100.00%
Short Term Provisions
106.53
28.14
78.39
278.57%
Total Current Liabilities
703.00
1,719.16
-1,016.16
-59.11%
Total Liabilities
1,476.56
5,416.11
-3,939.55
-72.74%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
162.41
2,880.91
-2,718.50
-94.36%
Less: Accumulated Depreciation
133.87
1,394.84
-1,260.97
-90.40%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
28.54
1,486.07
-1,457.53
-98.08%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
92.83
-92.83
-100.00%
Intangible assets under development
0.00
6.28
-6.28
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
677.65
-677.65
-100.00%
Long Term Loans & Advances
69.97
412.11
-342.14
-83.02%
Other Non Current Assets
0.00
8.13
-8.13
-100.00%
Total Non-Current Assets
134.21
2,956.06
-2,821.85
-95.46%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
548.50
1,038.18
-489.68
-47.17%
Sundry Debtors
184.88
1,190.56
-1,005.68
-84.47%
Cash and Bank
536.70
13.80
522.90
3,789.13%
Other Current Assets
16.20
50.76
-34.56
-68.09%
Short Term Loans and Advances
56.07
166.75
-110.68
-66.37%
Total Current Assets
1,342.35
2,460.05
-1,117.70
-45.43%
Net Current Assets (Including Current Investments)
639.35
740.89
-101.54
-13.71%
Total Current Assets Excluding Current Investments
1,342.35
2,460.05
-1,117.70
-45.43%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,476.56
5,416.11
-3,939.55
-72.74%
Contingent Liabilities
98.41
234.04
-135.63
-57.95%
Total Debt
0.00
655.82
-655.82
-100.00%
Book Value per share (adjusted)
308.14
159.61
148.53
93.06%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 38.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Annual - Fixed Assets
Fixed Assets 28.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,342.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
